Gene Transfer of Suicide Genes for the Treatment of Malignant Gliomas: Efficacy, Limitations, and Perspectives for a Combined Immunotherapy

Acta Neurochirurgica, Supplement

Volumn 1997, Issue 68, 1997, Pages 100-104

  Benedetti, S ^a   Di Meco, F ^a   Pollo, B ^a   Bruzzone, M G ^a   Cirenei, N ^a   Spreafico, R ^a   Solero, C L ^a   Broggi, G ^a   Di Donato, St ^a   Finocchiaro, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Ganciclovir; Gene therapy; Interleukin 4; Malignant gliomas; Retrovirus; Suicide gene

Indexed keywords

GANCICLOVIR; INTERLEUKIN 4; THYMIDINE KINASE;

ANIMAL; CELL DEATH; CELL DIVISION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOTHERAPY; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DEATH; CELL DIVISION; COMBINED MODALITY THERAPY; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-4; MICE; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0030630075     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6513-3_19     Document Type: Article

References (23)

1. Barba D, Hardin J, Jasodhara R, Gage FH (1993) Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 79: 729-735
2. Barba D, Hardin J, Sadelain M, Gage FH (1994) Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91: 4348-4352
3. Benedetti S, DiMeco F, Colombo BM, Cirenei N, Polio B, Bruzzone MG, Vescovi A, Colombo MP, DiDonato S, Finocchiaro G: Limits of the HSV-TK/GCV system for gene therapy of malignant gliomas: perspectives for the combined transduction of the IL-4 gene. Submitted
4. Beyer EC, Paul DL, Goodenough DA (1990) J Membr Biol 116: 187-194
5. Brooks WH, Markersbery WR, Gupta D, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 2: 219-224
6. Colombo BM, Benedetti S, Ottolenghi S, Poli G, Pollo B, Mora M, Finocchiaro G (1995) The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6: 763-772
7. Cool V, Pirotte B, Gérard C, Dargent J-L, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T (1996) Curative potential of Herpes Simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum Gene Ther 7: 627-635
8. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552
9. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716
10. Izquierdo M, Cortes M, de Felipe P, Martin V, Diez-Guerra J, Talavera A, Perez-Higuera A (1995) Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Therapy 2: 66-69
11. Li Bi W, Parysek LM, Warnick R, Stambrook PJ (1993) Hum Gene Ther 4: 725-731
12. Mahaley MS jr, Brooks WH, Roszman TL (1977) Immunobiology of primary intracranial tumors. I. Studies of the cellular and humoral general immune competence of brain tumor patients. J Neurosurg 46: 467-476
13. Markowitz D, Goff S, Bank A (1988) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167: 400-406
14. + lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 153: 5659-5673
15. Ram Z, Culver K, Oshiro E, Viola J, de Vroom H, Otto E, Long Z, McGarrity G, Muul G, Katz D, Blaese RM (1995) Summary of results and conclusion of the gene therapy of malignant brain tumors: clinical study. J Neurosurg 82: 343A
16. Sacco MG, Benedetti S, Duflot-Dancer A, Mesnil M, Bagnasco L, Strina D, Fasolo V, Villa A, Macchi P, Faranda S, Vezzoni P, Finocchiaro G (1996) Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retroviral mediated HSV-TK transfer in vivo. Gene Ther in press
17. Schold SC (1995) Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008-1012
18. Tepper RI, Pattengale PK, Leder P (1989) Murine Interleukin-4 displays potent anti-tumor activity in vivo. Cell 57: 503-512
19. Tepper RI, Coffman RL, Leder P (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548-551
20. Thomas DG, Lannigan CB, Behan PO (1975) Impaired cell mediated immunity in human brain tumors. Lancet 1: 1389-1390
21. Vile RG, Nelson JA, Castleden S, Chong H, Hart IR (1994) Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 54: 6228-6234
22. Wei MX, Tamiya T, Hurford RK, Boviatsis EJ, Tepper RI, Chiocca EA (1995) Enhancement of interleukin 4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 6: 437-443
23. Yu JS, Wei MX, Chiocca EA, Martuza L, Tepper RI (1993) Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res 53: 3125-3128